Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?

NCT03066726 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.

NCT NCT03066726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03066726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Cerebroplacental Ratio (CPR) Predict Adverse Outcomes in Low Risk Pregnancies?
Lead sponsor
Rutgers, The State University of New Jersey
Phase
Observational
Overall status
Terminated
Start date
May 15, 2017
Completion date
May 7, 2020
Enrollment
580 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cerebroplacental ratio